Efficacy and validity of automated quantitative chemiluminescent enzyme immunoassay for SARS-CoV-2 antigen test from saliva specimen in the diagnosis of COVID-19

INTRODUCTION: The pandemic of a novel coronavirus disease 2019 (COVID-19) caused by a severe acute respiratory coronavirus 2 (SARS-CoV-2) infection has been problematic worldwide. A new SARS-CoV-2 antigen test (LUMIPULSE(Ⓡ)) was licensed and widely used in Japan since May 2020. We conducted this stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Asai, Nobuhiro, Sakanashi, Daisuke, Ohashi, Wataru, Nakamura, Akiko, Kawamoto, Yuzuka, Miyazaki, Narimi, Ohno, Tomoko, Yamada, Atsuko, Chida, Sumie, Shibata, Yuichi, Kato, Hideo, Shiota, Arufumi, Hagihara, Mao, Koita, Isao, Yamagishi, Yuka, Suematsu, Hiroyuki, Ohta, Hirotoshi, Mikamo, Hiroshige
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017492/
https://www.ncbi.nlm.nih.gov/pubmed/33840598
http://dx.doi.org/10.1016/j.jiac.2021.03.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017492/
https://www.ncbi.nlm.nih.gov/pubmed/33840598
http://dx.doi.org/10.1016/j.jiac.2021.03.021

Ejemplares similares